- $134.17m
- $28.48m
- $33.03m
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
MaxCyte Inc expected to post a loss of 12 cents a share - Earnings Preview
RCS - MaxCyte, Inc. - Upcoming Investor Conferences
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options and Restricted Stock Units
MaxCyte, Inc. MaxCyte, Inc. - MXCR - MaxCyte Appoints Cynthia Collins to Board
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Results
MaxCyte, Inc. MaxCyte, Inc. - MXCR - MaxCyte Appoints Ali Soleymannezhad as CCO
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
Brief: Maxcyte Signs Strategic Platform License
MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
RCS - MaxCyte, Inc. - Bioprocessing Conference Participation
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing